AIG
TRIB

American International Group’s Trinity Biotech TRIB Stock Holding History

American International Group’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-25
Closed -$42K – 4344
2016
Q1 		$42K Buy
25
+1
+4% +$1.59K ﹤0.01% 3966
2015
Q4 		$43K Buy
24
+3
+14% +$5.31K ﹤0.01% 3988
2015
Q3 		$36K Buy
21
+5
+31% +$12.1K ﹤0.01% 4064
2015
Q2 		$44.5K Buy
16
+5
+45% +$13K ﹤0.01% 4086
2015
Q1 		$31.7K Buy
11
+3
+38% +$8.32K ﹤0.01% 4170
2014
Q4 		$21.6K Buy
8
+2
+33% +$5.17K ﹤0.01% 4307
2014
Q3 		$15.7K Buy
6
+3
+100% +$9.75K ﹤0.01% 4388
2014
Q2 		$10.4K Hold
3
– – ﹤0.01% 4478
2014
Q1 		$11K Sell
3
-20
-87% -$78.7K ﹤0.01% 4384
2013
Q4 		$87.7K Hold
23
– – ﹤0.01% 3440
2013
Q3 		$75.9K Sell
23
-11
-32% -$32.2K ﹤0.01% 3509
2013
Q2 		$84.7K Buy
+34
New +$84.6K ﹤0.01% 3266

Other funds holding TRIB

Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $2.25B AUM 44.61% 1-Year Est. Return
AAM
ACK Asset Management Greenwich, Connecticut $856M AUM 70.44% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
SM
Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

American International Group's TRIB Position: Q2 2016 in Review

American International Group sold out of Trinity Biotech (TRIB) in Q2 2016, closing a stake of 25 shares — an estimated $42K sold.

American International Group first reported a position in TRIB in Q2 2013 and held it in 12 quarters. The position peaked at $87.7K in Q4 2013. 79 funds tracked by Wall St. Rank hold TRIB as of Q2 2016.

  • American International Group reported no remaining Trinity Biotech position as of Q2 2016 after selling out during the quarter.
  • American International Group sold 25 Trinity Biotech shares in Q2 2016, an estimated $42K.
  • American International Group first reported a position in Trinity Biotech in Q2 2013 and held it in 12 quarters.
  • American International Group's Trinity Biotech position peaked at $87.7K in Q4 2013.
  • 79 funds tracked by Wall St. Rank held Trinity Biotech as of Q2 2016.

Based on American International Group's 13F filing for Q2 2016, filed 11 Aug 2016.